ScholarIQanswers from OpenAlex

Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial

PaperCitations, authors & open-access status

Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial have?

ScholarIQcitation count

Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial published?

ScholarIQyear

Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial has 2026 year in the ScholarIQ index.

What is the open-access status of Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial?

ScholarIQoa status

Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial has green oa status in the ScholarIQ index.

What is the DOI of Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial?

ScholarIQdoi

The DOI for Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial is on the source record.

What is the PMID of Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial?

ScholarIQpmid

The PMID for Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial is on the source record.

What is the OpenAlex record for Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial?

ScholarIQopenalex

The OpenAlex for Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial